476454-75-8

Basic information

• Product Name: 1-[6-(BROMOMETHYL)PYRIDIN-2-YL]ETHANONE
• Synonyms: 1-[6-(BROMOMETHYL)PYRIDIN-2-YL]ETHANONE
• CAS NO: 476454-75-8
• Molecular Formula: C₈H₈BrNO
• Molecular Weight: 214.06
• Mol File: 476454-75-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-[6-(BROMOMETHYL)PYRIDIN-2-YL]ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[6-(BROMOMETHYL)PYRIDIN-2-YL]ETHANONE(476454-75-8)
• EPA Substance Registry System: 1-[6-(BROMOMETHYL)PYRIDIN-2-YL]ETHANONE(476454-75-8)

Safety Data

• Hazardous Substances Data: 476454-75-8(Hazardous Substances Data)

Upstream product

• 135450-43-0 1-(6-(hydroxymethyl)pyridin-2-yl)ethan-1-one 
• 6940-57-4 2-acetyl-6-methylpyridine 
• 150058-63-2 2-bromo-6-({[dimethyl(2-methyl-2-propanyl)silyl]oxy}methyl)pyridine 
• 33674-96-3 2-bromo-6-(hydroxymethyl)pyridine 
• 162084-86-8 1-[6-(tert-butyl-dimethyl-silanyloxymethyl)-pyridin-2-yl]-ethanone 

Relevant articles and documents

NNN ligand compound, cobalt-NNN complex as well as preparation methods and application thereof

The invention relates to an NNN ligand compound with a coordination bond being formed by three N atoms, a cobalt-NNN complex formed by the NNN ligand compound, as well as preparation methods and application thereof. In particular, the NNN ligand compound contains pyridine and imine structures. The ligand compound and a cobalt complex thereof can efficiently catalyze the hydrosilylation reaction ofalkynes. The NNN ligand compound and the cobalt-NNN complex have the advantages of mild reaction conditions, high selectivity, wide substrate range, high yield and high purity. Moreover, the target product has higher economic value, and is suitable for industrialized production.

AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS

Compound that is an inhibitor of at least one of the A2A and A2B adenosine receptors, and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.

An NNN-Pincer-Cobalt Complex Catalyzed Highly Markovnikov-Selective Alkyne Hydrosilylation

A new NNN pincer (amine-pyridine-imine, API) cobalt complex, which is bench-stable and is applicable for the highly efficient and regioselective hydrosilylation of terminal alkynes, is developed. A broad set of α-vinylsilanes was successfully synthesized in good to high yields with up to 98/2 Markovnikov regioselectivity. This protocol can be readily scaled up for gram-scale synthesis and demonstrates the most efficient cobalt-catalyzed hydrosilylation of alkynes with turnover frequencies as high as 126720 h-1 to date.

COMPOUNDS USEFUL AS A3 ADENOSINE RECEPTOR AGONISTS

Compounds useful as A3 Adenosine Receptor Agonists. Adenosine analogue-type A3 receptor agonists having an N6 substituent of the formula CR20R21CYCLE where CYCLE is a specified heterocycle, e.g. a substituted pyridyl group or a substituted oxazolyl-containing bicyclic ring. 10